SW
PFE icon

SlateStone Wealth’s Pfizer PFE Stock Holding History

SlateStone Wealth’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-9,497
Closed -$252K – 296
2024
Q4 		$252K Buy
9,497
+508
+6% +$13.8K 0.02% 259
2024
Q3 		$260K Sell
8,989
-4
-0% -$117 0.02% 254
2024
Q2 		$252K Buy
8,993
+769
+9% +$21.2K 0.03% 256
2024
Q1 		$228K Buy
8,224
+522
+7% +$14.5K 0.02% 256
2023
Q4 		$222K Sell
7,702
-2,863
-27% -$86.5K 0.03% 219
2023
Q3 		$350K Sell
10,565
-1,409
-12% -$49.8K 0.05% 185
2023
Q2 		$439K Buy
11,974
+776
+7% +$30.2K 0.08% 149
2023
Q1 		$457K Sell
11,198
-3,367
-23% -$145K 0.09% 144
2022
Q4 		$746K Buy
14,565
+3,021
+26% +$145K 0.18% 92
2022
Q3 		$505K Sell
11,544
-18,216
-61% -$885K 0.13% 112
2022
Q2 		$1.56M Buy
29,760
+8,678
+41% +$442K 0.4% 55
2022
Q1 		$1.09M Buy
21,082
+12,483
+145% +$648K 0.24% 71
2021
Q4 		$508K Buy
8,599
+1,012
+13% +$50.1K 0.11% 118
2021
Q3 		$326K Buy
7,587
+1,412
+23% +$62.6K 0.07% 134
2021
Q2 		$242K Sell
6,175
-1,905
-24% -$74.1K 0.06% 153
2021
Q1 		$293K Sell
8,080
-26,571
-77% -$943K 0.07% 142
2020
Q4 		$1.28M Sell
34,651
-4,124
-11% -$151K 0.32% 73
2020
Q3 		$1.35M Sell
38,775
-27
-0.1% -$947 0.29% 85
2020
Q2 		$1.2M Sell
38,802
-36,796
-49% -$1.25M 0.27% 85
2020
Q1 		$2.34M Sell
75,598
-37,138
-33% -$1.27M 0.67% 43
2019
Q4 		$4.19M Sell
112,736
-15,792
-12% -$562K 0.96% 30
2019
Q3 		$4.38M Sell
128,528
-4,640
-3% -$169K 1.28% 20
2019
Q2 		$5.47M Sell
133,168
-3,401
-2% -$135K 1.54% 17
2019
Q1 		$5.5M Buy
136,569
+52,091
+62% +$2.09M 1.69% 15
2018
Q4 		$3.5M Buy
+84,478
New +$3.51M 1.61% 14

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SlateStone Wealth's PFE Position: Q1 2025 in Review

SlateStone Wealth sold out of Pfizer (PFE) in Q1 2025, closing a stake of 9,497 shares — an estimated $252K sold.

SlateStone Wealth first reported a position in PFE in Q4 2018 and held it in 25 quarters. The position peaked at $5.5M in Q1 2019. 2,931 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

  • SlateStone Wealth reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
  • SlateStone Wealth sold 9,497 Pfizer shares in Q1 2025, an estimated $252K.
  • SlateStone Wealth first reported a position in Pfizer in Q4 2018 and held it in 25 quarters.
  • SlateStone Wealth's Pfizer position peaked at $5.5M in Q1 2019.
  • 2,931 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on SlateStone Wealth's 13F filing for Q1 2025, filed 8 May 2025.